Codeine / Guaifenesin / Pseudoephedrine
Brand names
Available as
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Pediatric use
Contraindicated for pain or cough in children <12 years; carries an FDA boxed warning. Also contraindicated in children <18 after tonsillectomy/adenoidectomy and in adolescents 12–18 who are obese or have OSA/respiratory compromise, due to ultra-rapid metabolism and fatal respiratory depression.
Source: FDA Drug Safety Communication 2017; codeine prescribing information (boxed warning).
⚑ About half of pediatric medication use is off-label and not described in FDA labels — absence of pediatric information does not mean a medicine is unused or unsafe in children. Confirm with your clinician.
Current FDA labels (DailyMed)
- ZODRYL DEC 35 (CODEINE PHOSPHATE, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE) SUSPENSION [CODADOSE, INC.]
- CODITUSSIN DAC (CODEINE PHOSPHATE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SYRUP [GLENDALE INC]
- TRICODE GF (CODEINE PHOSPHATE, GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [RESPA PHARMACEUTICALS, INC.]
- ZODRYL DEC 60 (CODEINE PHOSPHATE, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE) SUSPENSION [CODADOSE, INC.]
- ZODRYL DEC 80 (CODEINE PHOSPHATE, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE) SUSPENSION [CODADOSE, INC.]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.